Darwin Knows

Home | Coverage | Agents | Pulse | LogIn | 


Marvel Biosciences Corp

Darwin Score+17
TickerMRVL
Latest Price0.16 CAD as of close on 04-Jul-2025
3 Month price range0.08 to 0.16 CAD
Market Capitalisation8.21Mn CAD
CountryCanada
RegionNorth America
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryBiotechnology
Sub-IndustryBiotechnology
Description
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The company's lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimer's disease and autism spectrum disorder, as well as depression and anxiety, ADHD, non-neurological conditions of cancer, and non-alcoholic steatohepatitis. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
See More ...
Company URLhttps://marvelbiotechnology.com
See Darwins Full Analysis for Marvel Biosciences Corp

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Marvel Biosciences Corp. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages+23
SentimentNews and Candle Patterns. -1
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.0
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.-5

Peer Comparison

There is 1 peer of Marvel Biosciences Corp.
Asset NameIndustry GroupPerf(20d)%Asset Score
Covalon Technologies Ltd (COV)Biotechnology+7.0+12

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn


To see complete information on Marvel Biosciences Corp or any other assets please login.


If you do not already have an account you can register for a free trial of our service. This will let you explore all the analytical information we have on price, fundamantals, flow, sentiments & models for all the stocks under coverage. You will then be able to compare asset scores and perform a wide range of multi asset analysis such as Market Cycles and Relative Scores.


Follow Us Followon Twitter Share on LinkedIn

©2025 Darwin Knows - All Rights Reserved